CDC27P2

Across TCGA pan-cancer cohorts, CDC27P2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CDC27P2 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher CDC27P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDC27P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

CHOL, COAD, and ESCA are the cancer types where CDC27P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	All	0.055	0.499	.001	72	view →
COAD	DFS	Tertile	All	0.199	0.541	<.001	36	view →
ESCA	DFS	Median	All	0.614	0.422	.004	24	view →
HNSC	DFS	Tertile	IV	0.532	0.694	.009	21	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
READ	OS	Tertile	All	0.641	0.848	.015	15	view →
THCA	DFS	Tertile	II,III,IV	1.000	0.718	.037	9	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
STAD	DFS	Tertile	IV	0.681	0.155	.010	6	view →
OV	OS	Tertile	IV	0.895	0.579	.036	6	view →
LGG	OS	Tertile	All	0.826	0.905	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CDC27P2–CHOL (DFS)

Open the CHOL breakdown →